Abstract
Angiogenesis is associated with the progression of multiple myeloma (MM). Wogonin is an active mono-flavonoid with remarkable antitumor activity. However, its impact on MM-stimulated angiogenesis remains largely unknown. Here, we demonstrated that wogonin decreased expression and secretion of pro-angiogenic factors in MM cells via c-Myc/HIF-1a signaling axis, reducing MM-stimulated angiogenesis and MM cell proliferation in vivo. Overexpression of c-Myc in MM cells disrupted the balance between VHL SUMOylation and ubiquitination, and thus inhibited proteasome-mediated HIF-1a degradation. Impaired function of VHL ubiquitination complex in c-Myc-overexpressing cells was fully reversed by wogonin treatment via increasing HIF-1a-VHL interaction and promoting HIF-1a degradation. Collectively, our in vitro and in vivo studies reveal for the first time that wogonin represses MM-stimulated angiogenesis and tumor progression via c-Myc/VHL/HIF-1a signaling axis.
Author supplied keywords
Cite
CITATION STYLE
Fu, R., Chen, Y., Wang, X. P., An, T., Tao, L., Zhou, Y. X., … Wu, Z. Q. (2016). Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1a signaling axis. Oncotarget, 7(5), 5715–5727. https://doi.org/10.18632/oncotarget.6796
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.